299 related articles for article (PubMed ID: 21727925)
1. What are the anticoagulation options for intermittent hemodialysis?
Davenport A
Nat Rev Nephrol; 2011 Jul; 7(9):499-508. PubMed ID: 21727925
[TBL] [Abstract][Full Text] [Related]
2. The safety of heparins in end-stage renal disease.
Sonawane S; Kasbekar N; Berns JS
Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
[TBL] [Abstract][Full Text] [Related]
3. Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.
Davenport A
Pediatr Nephrol; 2012 Oct; 27(10):1869-79. PubMed ID: 22374405
[TBL] [Abstract][Full Text] [Related]
4. The rationale for the use of low molecular weight heparin for hemodialysis treatments.
Davenport A
Hemodial Int; 2013 Oct; 17 Suppl 1():S28-32. PubMed ID: 24134328
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin for routine hemodialysis.
Davenport A
Hemodial Int; 2008 Oct; 12 Suppl 2():S34-7. PubMed ID: 18837768
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation options for intermittent haemodialysis.
Davenport A
Minerva Urol Nefrol; 2006 Jun; 58(2):171-80. PubMed ID: 16767070
[TBL] [Abstract][Full Text] [Related]
7. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
Ryckelynck JP; Chouraqui D; Lobbedez T
Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
[TBL] [Abstract][Full Text] [Related]
9. Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis.
Shen JI; Winkelmayer WC
Am J Kidney Dis; 2012 Sep; 60(3):473-86. PubMed ID: 22560830
[TBL] [Abstract][Full Text] [Related]
10. Unfractionated heparin for hemodialysis: still the best option.
Cronin RE; Reilly RF
Semin Dial; 2010; 23(5):510-5. PubMed ID: 21039876
[TBL] [Abstract][Full Text] [Related]
11. How to Ensure Patency of the Extracorporeal Circuit in Hemodialysis: Global Perspectives.
Santos A; Vega A; Davenport A
Semin Nephrol; 2023 Nov; 43(6):151476. PubMed ID: 38272778
[TBL] [Abstract][Full Text] [Related]
12. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
13. Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help.
Janssens FV; Meijers B; François K
Semin Nephrol; 2023 Nov; 43(6):151483. PubMed ID: 38220473
[TBL] [Abstract][Full Text] [Related]
14. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
15. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
16. [Anticoagulation and chronic hemodialysis].
Zerbi S; Pedrini LA
G Ital Nefrol; 2007; 24(5):381-95. PubMed ID: 17886208
[TBL] [Abstract][Full Text] [Related]
17. Optimization of heparin anticoagulation for hemodialysis.
Davenport A
Hemodial Int; 2011 Oct; 15 Suppl 1():S43-8. PubMed ID: 22093600
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of single bolus anticoagulation with enoxaparin for chronic hemodialysis. Results of an open-label post-certification study.
Klingel R; Schwarting A; Lotz J; Eckert M; Hohmann V; Hafner G
Kidney Blood Press Res; 2004; 27(4):211-7. PubMed ID: 15273423
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials.
Lim W; Cook DJ; Crowther MA
J Am Soc Nephrol; 2004 Dec; 15(12):3192-206. PubMed ID: 15579523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
